NAM works to change lives by sharing information about HIV and AIDS. We believe independent, clear and accurate information is vital in the fight against HIV and AIDS. More about us >

Results from the START trial

A major international randomised clinical trial has found that starting HIV treatment at a CD4 count over 500 is safer than waiting until the CD4 count falls to 350.

Results from the START trial

A major international randomised clinical trial has found that starting HIV treatment at a CD4 count over 500 is safer than waiting until the CD4 count falls to 350.

HIV & hepatitis booklet

We have recently published a new edition of the HIV & hepatitis booklet in our HIV information series. It covers key information on hepatitis for people living with HIV, which can help you think about what you want to discuss with your doctor or nurse.

The Avahan programme

Two recent studies investigated the implementation of a huge programme of HIV prevention through community mobilisation in India. The Avahan programme aimed to replicate the success of a project in Kolkata, credited with improving rates of condom use, STIs and experience of violence among sex workers.

Conference news: EASL

The International Liver Congress 2015 (ILC 2015), the 50th annual meeting of the European Association for the Study of the Liver (EASL), took place in Vienna, Austria, in April.

New edition: Having a baby

We've recently published a new edition of the Having a baby leaflet in our illustrated series, The basics. This series is designed to support discussions between professionals and people living with HIV, and is written in simple language.

aidsmap HIV & AIDS news

More news from aidsmap

Editor's picks from other sources

More Editor's picks

E-atlas Thailand

Find news, resources and services from Thailand
Or select a country from the list below

A to Z of topics